We are live on ! Find out more
HC

Hampstead Capital Portfolio holdings

AUM $55.8M
1-Year Est. Return 2.76%
This Fund
S&P 500
This Quarter Est. Return
+0.77%
1 Year Est. Return
+2.76%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$53.2M
AUM Growth
-$21.2M
Cap. Flow
-$21.2M
Cap. Flow %
-39.86%
Top 10 Hldgs %
72.93%
Holding
29
New
–
Increased
3
Reduced
21
Closed
5

Top Buys

Rank Stock Value
1
PM icon
Philip Morris
PM
+$662K
2
XPRO icon
Expro Ltd
XPRO
+$124K
3
RY icon
Royal Bank of Canada
RY
+$91.9K

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$2.13M
2
VTRS icon
Viatris
VTRS
+$2.06M
3
PXD
Pioneer Natural Resource Co.
PXD
+$2.01M
4
EXC icon
Exelon
EXC
+$1.79M
5
T icon
AT&T
T
+$1.73M

Sector Composition

Rank Sector Weight
1 Energy 20.49%
2 Communication Services 19.84%
3 Utilities 15.75%
4 Consumer Staples 15.37%
5 Healthcare 14.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
T icon
1
AT&T
T
$159B
$4.69M 8.82%
193,569
-69,113
-26% -$1.73M
XOM icon
2
ExxonMobil
XOM
$644B
$3.85M 7.23%
46,500
-4,500
-9% -$359K
VZ icon
3
Verizon
VZ
$195B
$3.83M 7.2%
76,100
-4,100
-5% -$198K
CVX icon
4
Chevron
CVX
$392B
$3.82M 7.18%
30,200
-2,400
-7% -$298K
KO icon
5
Coca-Cola
KO
$377B
$3.8M 7.14%
86,600
-1,900
-2% -$82.1K
PM icon
6
Philip Morris
PM
$297B
$3.79M 7.13%
47,000
+7,800
+20% +$662K
RY icon
7
Royal Bank of Canada
RY
$291B
$3.77M 7.09%
50,100
+1,200
+2% +$91.9K
SO icon
8
Southern Company
SO
$109B
$3.77M 7.09%
81,400
-4,700
-5% -$210K
PFE icon
9
Pfizer
PFE
$143B
$3.74M 7.03%
108,667
-4,427
-4% -$151K
PPL
10
PPL Corp
PPL
$26.5B
$3.73M 7.02%
130,800
-6,600
-5% -$183K
TMUS icon
11
T-Mobile US
TMUS
$185B
$2.03M 3.82%
34,000
-11,000
-24% -$651K
INVX
12
Innovex International
INVX
$1.96B
$1.47M 2.75%
28,500
-11,500
-29% -$536K
GILD icon
13
Gilead Sciences
GILD
$162B
$1.45M 2.73%
20,500
-16,500
-45% -$1.17M
FLR icon
14
Fluor
FLR
$7.01B
$1.15M 2.15%
23,500
-6,500
-22% -$340K
AIG icon
15
American International
AIG
$41.7B
$1.14M 2.14%
21,500
-18,500
-46% -$1M
XPRO icon
16
Expro Ltd
XPRO
$1.79B
$917K 1.72%
19,583
+2,916
+17% +$124K
CELG
17
DELISTED
Celgene Corp
CELG
$874K 1.64%
11,000
-7,000
-39% -$581K
EXC icon
18
Exelon
EXC
$47.2B
$873K 1.64%
28,741
-62,389
-68% -$1.79M
PXD
19
DELISTED
Pioneer Natural Resource Co.
PXD
$852K 1.6%
4,500
-10,500
-70% -$2.01M
TSE
20
DELISTED
Trinseo
TSE
$851K 1.6%
12,000
-3,000
-20% -$223K
MRK icon
21
Merck
MRK
$322B
$850K 1.6%
14,672
-37,728
-72% -$2.13M
VTRS icon
22
Viatris
VTRS
$20.4B
$813K 1.53%
22,500
-52,500
-70% -$2.06M
PG icon
23
Procter & Gamble
PG
$336B
$585K 1.1%
7,500
-17,500
-70% -$1.32M
GM icon
24
General Motors
GM
$80.4B
$552K 1.04%
14,000
-11,000
-44% -$433K
CTRA
25
DELISTED
Coterra Energy
CTRA
– –
-15,000
Closed -$360K
1
2

Similar funds

CCP
Centaur Capital Partners Southlake, Texas $54.1M AUM 12.4% 1-Year Est. Return
PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
CLA
Cranberry Lake Advisors Houston, Texas $50.6M AUM 5.12% 1-Year Est. Return
EIC
ENA Investment Capital London, United Kingdom $61.8M AUM
SF
Schooner Foundation Boston, Massachusetts $49.6M AUM 9.4% 1-Year Est. Return
DIV
DCM International V Menlo Park, California $47.8M AUM 19.52% 1-Year Est. Return
MGPI
Maveron General Partner III Seattle, Washington $46.7M AUM 35.29% 1-Year Est. Return
BOIA
Bush ODonnell Investment Advisors St Louis, Missouri $65.2M AUM 13.39% 1-Year Est. Return

Hampstead Capital's Q2 2018 Portfolio in Review

As of Q2 2018, Hampstead Capital held 29 positions worth $53.2M, down 29% from $74.4M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Hampstead Capital withdrew a net $21.2M in Q2 2018, closing 5 positions and reducing 21 holdings. Its most notable exit was Goldcorp Inc, an estimated $1.66M position sold in full.

By sector, the portfolio is most concentrated in Energy at 20% of assets, up from 18% a quarter earlier, followed by Communication Services and Utilities.

Against the trend, Hampstead Capital added an estimated $662K to Philip Morris.

  • Hampstead Capital added most to Philip Morris in Q2 2018, an estimated $662K increase.
  • Hampstead Capital's biggest Q2 2018 reduction was Merck, cutting an estimated $2.13M.
  • Hampstead Capital fully exited Goldcorp Inc in Q2 2018, selling an estimated $1.66M.
  • Hampstead Capital's ten largest holdings make up 73% of its $53.2M portfolio in Q2 2018.
  • Hampstead Capital opened 0 new positions and closed 5 in Q2 2018.
  • Hampstead Capital's portfolio value fell 29% quarter-over-quarter to $53.2M.

Based on Hampstead Capital's 13F filing for Q2 2018, filed 14 Aug 2018.